多汗症治療市場：タイプ、治療法、エンドユーザー別-2025-2030年の世界予測

多汗症治療市場は、2023年に6億1,713万米ドルと評価され、2024年には6億4,788万米ドルに達すると予測され、CAGR 6.70％で成長し、2030年には9億7,232万米ドルに達すると予測されています。

多汗症治療は、感情的、社会的、職業的苦痛により個人のQOLに影響を与える発汗過多の問題に対処します。市場の必要性は、世界人口の5％近くが罹患している多汗症の著しい有病率に起因しています。治療は、外用液や内服薬から、ボトックス注射、イオントフォレーシス、外科的交感神経切除術のような侵襲的な処置まで多岐にわたる。主な最終用途には、病院、皮膚科クリニック、在宅ケアなどがあり、患者の個別ニーズに応える多様な用途が反映されています。多汗症治療市場の成長を後押ししているのは、利用可能な治療法に関する認知度の向上、技術の進歩、FDA承認の治療法の市場参入です。また、美容医療に対する消費意欲の高まりも需要を大きく後押ししています。心強いことに、現在進行中の臨床試験や研究開発イニシアティブは、特に副作用の少ない非侵襲的治療の開発において、新たな機会を提示しています。この分野で有望な分野は、持続的な効果と最小限の回復時間により可能性を秘めた、機器ベースの治療の拡大です。しかし、高額な治療費、潜在的な副作用、特に後発開発途上地域においては普及が進んでいないため、限界が存在します。また、多汗症にまつわるスティグマ（烙印）も、治療を受けようとしない人が多いことから、市場拡大の制約となっています。こうした課題を克服するため、企業は費用対効果の高い革新的なソリューションの開発に注力することができます。おそらくウェアラブル技術やAIを活用した個別化治療によって、アクセスを民主化し、患者のコンプライアンスを向上させることができると思われます。さらに、効果的な診察の手段として遠隔医療サービスを確立することで、十分に浸透していない市場にリーチできる可能性があります。非侵襲的で患者に優しい選択肢への関心がますます高まる中、市場の性質はダイナミックであり、患者中心のイノベーション、協力的なヘルスケア・パートナーシップ、的を絞った啓発キャンペーンを優先する企業が報われ、着実に拡大すると予想されます。

市場力学：急速に進化する多汗症治療市場の主要市場インサイトを公開

多汗症治療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 腋窩多汗症の有病率の上昇
  • 処方されるクリームやワイプの入手可能性の増加
  • 局所治療の採用急増
• 市場抑制要因
  • 多汗症治療による健康への悪影響
• 市場機会
  • 新しい治療薬や薬剤のイントロダクション
  • 継続的な研究活動と承認の増加
• 市場の課題
  • 認識不足と償還政策の問題

ポーターのファイブフォース：多汗症治療市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：多汗症治療市場における外部からの影響の把握

外部マクロ環境要因は、多汗症治療市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析多汗症治療市場における競合情勢の把握

多汗症治療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス多汗症治療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、多汗症治療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨多汗症治療市場における成功への道筋を描く

多汗症治療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 腋窩多汗症の罹患率の上昇
    • 処方されたクリームや拭き取り用品の入手性の向上
    • 局所治療の採用急増
  • 抑制要因
    • 多汗症治療の健康への悪影響
  • 機会
    • 新しい治療法や薬剤のイントロダクション
    • 進行中の調査活動と承認の増加
  • 課題
    • 認識不足と払い戻しポリシーの問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 多汗症治療市場：タイプ別

• 原発性多汗症
• 二次性全身性多汗症

第7章 多汗症治療市場治療別

• ボツリヌス毒素注射
• マイクロ波療法
• 経口薬
• 外科的治療
• 局所治療

第8章 多汗症治療市場：エンドユーザー別

• 外来手術センター
• 皮膚科クリニック
• 支払者と患者

第9章 南北アメリカの多汗症治療市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の多汗症治療市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの多汗症治療市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• Cynosure, LLC
• Dermadry Laboratories Inc.
• Dr. August Wolff GmbH & Co. KG
• Eli Lilly and Company
• Fresh Tracks Therapeutics, Inc.
• GlaxoSmithKline PLC
• Miramar Lab Inc.
• Revance Therapeutics, Inc.
• Sesderma, S.L.
• TheraVida, Inc.
• Ulthera, Inc. by Merz North America, Inc.

LIST OF FIGURES

• FIGURE 1. HYPERHIDROSIS TREATMENT MARKET RESEARCH PROCESS
• FIGURE 2. HYPERHIDROSIS TREATMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. HYPERHIDROSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. HYPERHIDROSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HYPERHIDROSIS TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HYPERHIDROSIS TREATMENT MARKET DYNAMICS
• TABLE 7. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRIMARY HYPERHIDROSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY SECONDARY GENERALIZED HYPERHIDROSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY BOTULINUM TOXIN INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY MICROWAVE THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY PAYERS & PATIENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 32. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. CHINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CHINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 49. CHINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. INDIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 52. INDIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. ITALY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ITALY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 104. ITALY HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. POLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. POLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 116. POLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. QATAR HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. QATAR HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 119. QATAR HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. HYPERHIDROSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 148. HYPERHIDROSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

The Hyperhidrosis Treatment Market was valued at USD 617.13 million in 2023, expected to reach USD 647.88 million in 2024, and is projected to grow at a CAGR of 6.70%, to USD 972.32 million by 2030.

Hyperhidrosis treatment addresses excessive sweating issues, impacting individuals' quality of life due to emotional, social, and occupational distress. The market's necessity stems from the significant prevalence of hyperhidrosis, affecting nearly 5% of the global population. Treatments range from topical solutions and oral medications to more invasive procedures like Botox injections, iontophoresis, and surgical sympathectomy. Key end-use segments include hospitals, dermatology clinics, and home-care settings, reflecting the diverse applications that cater to personalized patient needs. The hyperhidrosis treatment market's growth is propelled by increased awareness about available therapies, technological advancements, and more FDA-approved treatments entering the market. Rising consumer willingness to spend on aesthetic procedures also significantly boosts demand. Encouragingly, ongoing clinical trials and R&D initiatives are presenting novel opportunities, particularly in developing non-invasive treatments with minimal side effects. A promising area within this field is the expansion of device-based treatments, which hold potential due to their lasting effects and minimal recovery time. However, limitations exist due to the high treatment costs, potential side effects, and lack of widespread accessibility, especially in less-developed regions. The stigma associated with hyperhidrosis also constrains market expansion, as many individuals may not seek treatment. To navigate these challenges, businesses can focus on developing cost-effective and innovative solutions, perhaps through wearable tech or AI-driven personalized treatments, which could democratize access and improve patient compliance. Moreover, establishing telemedicine services as an avenue for effective consultation could reach underpenetrated markets. With an ever-growing interest in non-invasive, patient-friendly options, the market's nature is dynamic and expected to expand steadily, rewarding companies that prioritize patient-centric innovations, collaborative healthcare partnerships, and targeted awareness campaigns.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hyperhidrosis Treatment Market

The Hyperhidrosis Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of axillary hyperhidrosis
  • Increasing availability of prescribed creams and wipe
  • Surg in adoption of topical treatment
• Market Restraints
  • Adverse health impacts of hyperhidrosis treatment
• Market Opportunities
  • Introduction of new therapeutics and drugs
  • Ongoing research activities and rising approvals
• Market Challenges
  • Lack of awareness and reimbursement policies issues

Porter's Five Forces: A Strategic Tool for Navigating the Hyperhidrosis Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hyperhidrosis Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hyperhidrosis Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hyperhidrosis Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hyperhidrosis Treatment Market

A detailed market share analysis in the Hyperhidrosis Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hyperhidrosis Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hyperhidrosis Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hyperhidrosis Treatment Market

A strategic analysis of the Hyperhidrosis Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hyperhidrosis Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Cynosure, LLC, Dermadry Laboratories Inc., Dr. August Wolff GmbH & Co. KG, Eli Lilly and Company, Fresh Tracks Therapeutics, Inc., GlaxoSmithKline PLC, Miramar Lab Inc., Revance Therapeutics, Inc., Sesderma, S.L., TheraVida, Inc., and Ulthera, Inc. by Merz North America, Inc..

Market Segmentation & Coverage

This research report categorizes the Hyperhidrosis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Primary Hyperhidrosis and Secondary Generalized Hyperhidrosis.
• Based on Treatment, market is studied across Botulinum Toxin Injections, Microwave Therapy, Oral Medication, Surgical Treatment, and Topical Treatment.
• Based on End-User, market is studied across Ambulatory Surgery Centers, Dermatology Clinics, and Payers & Patients.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of axillary hyperhidrosis
    • 5.1.1.2. Increasing availability of prescribed creams and wipe
    • 5.1.1.3. Surg in adoption of topical treatment
  • 5.1.2. Restraints
    • 5.1.2.1. Adverse health impacts of hyperhidrosis treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of new therapeutics and drugs
    • 5.1.3.2. Ongoing research activities and rising approvals
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of awareness and reimbursement policies issues
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Hyperhidrosis Treatment Market, by Type

• 6.1. Introduction
• 6.2. Primary Hyperhidrosis
• 6.3. Secondary Generalized Hyperhidrosis

7. Hyperhidrosis Treatment Market, by Treatment

• 7.1. Introduction
• 7.2. Botulinum Toxin Injections
• 7.3. Microwave Therapy
• 7.4. Oral Medication
• 7.5. Surgical Treatment
• 7.6. Topical Treatment

8. Hyperhidrosis Treatment Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgery Centers
• 8.3. Dermatology Clinics
• 8.4. Payers & Patients

9. Americas Hyperhidrosis Treatment Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Hyperhidrosis Treatment Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Hyperhidrosis Treatment Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Cynosure, LLC
• 3. Dermadry Laboratories Inc.
• 4. Dr. August Wolff GmbH & Co. KG
• 5. Eli Lilly and Company
• 6. Fresh Tracks Therapeutics, Inc.
• 7. GlaxoSmithKline PLC
• 8. Miramar Lab Inc.
• 9. Revance Therapeutics, Inc.
• 10. Sesderma, S.L.
• 11. TheraVida, Inc.
• 12. Ulthera, Inc. by Merz North America, Inc.